ArticleJournal of hematology & oncology2012

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.

Yuka Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.